BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 32109419)

  • 1. Opposite Modulation of RAC1 by Mutations in TRIO Is Associated with Distinct, Domain-Specific Neurodevelopmental Disorders.
    Barbosa S; Greville-Heygate S; Bonnet M; Godwin A; Fagotto-Kaufmann C; Kajava AV; Laouteouet D; Mawby R; Wai HA; Dingemans AJM; Hehir-Kwa J; Willems M; Capri Y; Mehta SG; Cox H; Goudie D; Vansenne F; Turnpenny P; Vincent M; Cogné B; Lesca G; Hertecant J; Rodriguez D; Keren B; Burglen L; Gérard M; Putoux A; ; Cantagrel V; Siquier-Pernet K; Rio M; Banka S; Sarkar A; Steeves M; Parker M; Clement E; Moutton S; Tran Mau-Them F; Piton A; de Vries BBA; Guille M; Debant A; Schmidt S; Baralle D
    Am J Hum Genet; 2020 Mar; 106(3):338-355. PubMed ID: 32109419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More evidence on TRIO missense mutations in the spectrin repeat domain causing severe developmental delay and recognizable facial dysmorphism with macrocephaly.
    Kloth K; Graul-Neumann L; Hermann K; Johannsen J; Bierhals T; Kortüm F
    Neurogenetics; 2021 Jul; 22(3):221-224. PubMed ID: 34013494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodevelopmental disease-associated de novo mutations and rare sequence variants affect TRIO GDP/GTP exchange factor activity.
    Katrancha SM; Wu Y; Zhu M; Eipper BA; Koleske AJ; Mains RE
    Hum Mol Genet; 2017 Dec; 26(23):4728-4740. PubMed ID: 28973398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic TRIO variants associated with neurodevelopmental disorders perturb the molecular regulation of TRIO and axon pathfinding in vivo.
    Bonnet M; Roche F; Fagotto-Kaufmann C; Gazdagh G; Truong I; Comunale F; Barbosa S; Bonhomme M; Nafati N; Hunt D; Rodriguez MP; Chaudhry A; Shears D; Madruga M; Vansenne F; Curie A; Kajava AV; Baralle D; Fassier C; Debant A; Schmidt S
    Mol Psychiatry; 2023 Apr; 28(4):1527-1544. PubMed ID: 36717740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Rac1- and RhoG-specific GEF domain of Trio targets filamin to remodel cytoskeletal actin.
    Bellanger JM; Astier C; Sardet C; Ohta Y; Stossel TP; Debant A
    Nat Cell Biol; 2000 Dec; 2(12):888-92. PubMed ID: 11146652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of TRIO-GEFD1 chemical inhibitors using the yeast exchange assay.
    Blangy A; Bouquier N; Gauthier-Rouvière C; Schmidt S; Debant A; Leonetti JP; Fort P
    Biol Cell; 2006 Sep; 98(9):511-22. PubMed ID: 16686599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autism Spectrum Disorder/Intellectual Disability-Associated Mutations in Trio Disrupt Neuroligin 1-Mediated Synaptogenesis.
    Tian C; Paskus JD; Fingleton E; Roche KW; Herring BE
    J Neurosci; 2021 Sep; 41(37):7768-7778. PubMed ID: 34353896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of guanine nucleotide exchange and Rac-mediated signaling revealed by a dominant negative trio mutant.
    Debreceni B; Gao Y; Guo F; Zhu K; Jia B; Zheng Y
    J Biol Chem; 2004 Jan; 279(5):3777-86. PubMed ID: 14597635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of the multifunctional Trio protein in the control of the Rac1 and RhoA gtpase signaling pathways].
    Bellanger JM; Zugasti O; Lazaro JB; Diriong S; Lamb N; Sardet C; Debant A
    C R Seances Soc Biol Fil; 1998; 192(2):367-74. PubMed ID: 9759378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An autism spectrum disorder-related de novo mutation hotspot discovered in the GEF1 domain of Trio.
    Sadybekov A; Tian C; Arnesano C; Katritch V; Herring BE
    Nat Commun; 2017 Sep; 8(1):601. PubMed ID: 28928363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Human Rho-GEF trio and its target GTPase RhoG are involved in the NGF pathway, leading to neurite outgrowth.
    Estrach S; Schmidt S; Diriong S; Penna A; Blangy A; Fort P; Debant A
    Curr Biol; 2002 Feb; 12(4):307-12. PubMed ID: 11864571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations specific to the Rac-GEF domain of
    Pengelly RJ; Greville-Heygate S; Schmidt S; Seaby EG; Jabalameli MR; Mehta SG; Parker MJ; Goudie D; Fagotto-Kaufmann C; Mercer C; ; Debant A; Ennis S; Baralle D
    J Med Genet; 2016 Nov; 53(11):735-742. PubMed ID: 27418539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of autism spectrum disorder-related pathogenic trio variants by a novel structure-based approach.
    Rao S; Sadybekov A; DeWitt DC; Lipka J; Katritch V; Herring BE
    Mol Autism; 2024 Apr; 15(1):12. PubMed ID: 38566250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct functions of Trio GEF domains in axon outgrowth of cerebellar granule neurons.
    Tao T; Sun J; Peng Y; Wang P; Chen X; Zhao W; Li Y; Wei L; Wang W; Zheng Y; Wang Y; Zhang X; Zhu MS
    J Genet Genomics; 2019 Feb; 46(2):87-96. PubMed ID: 30850274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAC1 Missense Mutations in Developmental Disorders with Diverse Phenotypes.
    Reijnders MRF; Ansor NM; Kousi M; Yue WW; Tan PL; Clarkson K; Clayton-Smith J; Corning K; Jones JR; Lam WWK; Mancini GMS; Marcelis C; Mohammed S; Pfundt R; Roifman M; Cohn R; Chitayat D; ; Millard TH; Katsanis N; Brunner HG; Banka S
    Am J Hum Genet; 2017 Sep; 101(3):466-477. PubMed ID: 28886345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DH and PH domains of Trio coordinately engage Rho GTPases for their efficient activation.
    Chhatriwala MK; Betts L; Worthylake DK; Sondek J
    J Mol Biol; 2007 May; 368(5):1307-20. PubMed ID: 17391702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The N-terminal DH-PH domain of Trio induces cell spreading and migration by regulating lamellipodia dynamics in a Rac1-dependent fashion.
    van Rijssel J; Hoogenboezem M; Wester L; Hordijk PL; Van Buul JD
    PLoS One; 2012; 7(1):e29912. PubMed ID: 22238672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling human mutations to understand TRIO GEF function during development.
    Fingleton E; Roche KW
    Trends Neurosci; 2023 Jun; 46(6):411-412. PubMed ID: 36959051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Rho guanine nucleotide exchange factor Trio is required for neural crest cell migration and interacts with Dishevelled.
    Kratzer MC; Becker SFS; Grund A; Merks A; Harnoš J; Bryja V; Giehl K; Kashef J; Borchers A
    Development; 2020 May; 147(10):. PubMed ID: 32366678
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.